{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:25:04Z","timestamp":1794230704806,"version":"4.9.0"},"reference-count":397,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The test-negative design is an increasingly popular approach for estimating vaccine effectiveness (VE) due to its efficiency. This review aims to examine published test-negative design studies of VE and to explore similarities and differences in methodological choices for different diseases and vaccines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We conducted a systematic search on PubMed, Web of Science, and Medline, for studies reporting the effectiveness of any vaccines using a test-negative design. We screened titles and abstracts and reviewed full texts to identify relevant articles. We created a standardized form for each included article to extract information on the pathogen of interest, vaccine(s) being evaluated, study setting, clinical case definition, choices of cases and controls, and statistical approaches used to estimate VE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>We identified a total of 348 articles, including studies on VE against influenza virus (n = 253), rotavirus (n = 48), pneumococcus (n = 24), and nine other pathogens. Clinical case definitions used to enroll patients were similar by pathogens of interest but the sets of symptoms that defined them varied substantially. Controls could be those testing negative for the pathogen of interest, those testing positive for nonvaccine type of the pathogen of interest, or a subset of those testing positive for alternative pathogens. Most studies controlled for age, calendar time, and comorbidities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Our review highlights similarities and differences in the application of the test-negative design that deserve further examination. If vaccination reduces disease severity in breakthrough infections, particular care must be taken in interpreting vaccine effectiveness estimates from test-negative design studies.<\/jats:p><\/jats:sec>","DOI":"10.1097\/ede.0000000000001116","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T22:17:03Z","timestamp":1570832223000},"page":"43-64","source":"Crossref","is-referenced-by-count":177,"title":["The Use of Test-negative Controls to Monitor Vaccine Effectiveness"],"prefix":"10.1097","volume":"31","author":[{"given":"Huiying","family":"Chua","sequence":"first","affiliation":[{"name":"World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Feng","sequence":"additional","affiliation":[{"name":"World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Lewnard","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena G.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, and Doherty Department, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia"},{"name":"Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA"},{"name":"Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Blyth","sequence":"additional","affiliation":[{"name":"Division of Paediatrics, School of Medicine, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia"},{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia"},{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lipsitch","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA"},{"name":"Center for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Cowling","sequence":"additional","affiliation":[{"name":"World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","article-title":"The contribution of vaccination to global health: past, present and future.","volume":"369","author":"Greenwood","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"30519","DOI":"10.2807\/1560-7917.ES.2017.22.17.30519","article-title":"Immunisation information systems - useful tools for monitoring vaccination programmes in EU\/EEA countries, 2016.","volume":"22","author":"Derrough","year":"2017","journal-title":"Euro Surveill"},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ije\/13.1.87","article-title":"Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies.","volume":"13","author":"Smith","year":"1984","journal-title":"Int J Epidemiol"},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1016\/j.vaccine.2017.04.035","article-title":"Case-control vaccine effectiveness studies: data collection, analysis and reporting results.","volume":"35","author":"Verani","year":"2017","journal-title":"Vaccine"},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/oxfordjournals.aje.a116396","article-title":"Selection of controls in case-control studies. I. Principles.","volume":"135","author":"Wacholder","year":"1992","journal-title":"Am J Epidemiol"},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2307\/3002000","article-title":"Limitations of the application of fourfold table analysis to hospital data.","volume":"2","author":"Berkson","year":"1946","journal-title":"Biometrics"},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2017.04.037","article-title":"Case-control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls.","volume":"35","author":"Verani","year":"2017","journal-title":"Vaccine"},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/kww064","article-title":"Theoretical basis of the Test-Negative Study Design for assessment of influenza vaccine effectiveness.","volume":"184","author":"Sullivan","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"pii=1800103","DOI":"10.2807\/1560-7917.ES.2018.23.10.18-00103","article-title":"A concern over terminology in vaccine effectiveness studies.","volume":"23","author":"Cowling","year":"2018","journal-title":"Euro Surveill"},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/EDE.0000000000000343","article-title":"\u201cCrude Vaccine Effectiveness\u201d is a misleading term in test-negative studies of influenza vaccine effectiveness.","volume":"26","author":"Sullivan","year":"2015","journal-title":"Epidemiology"},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1586\/14760584.2014.966695","article-title":"Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.","volume":"13","author":"Sullivan","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.vaccine.2015.01.069","article-title":"Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.","volume":"33","author":"Jackson","year":"2015","journal-title":"Vaccine"},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"20585","DOI":"10.2807\/1560-7917.ES2013.18.37.20585","article-title":"The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials.","volume":"18","author":"De Serres","year":"2013","journal-title":"Euro Surveill"},{"key":"R15-20230908","first-page":"2060","article-title":"Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies.","volume":"45","author":"Lipsitch","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM198009043031003","article-title":"Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.","volume":"303","author":"Broome","year":"1980","journal-title":"N Engl J Med"},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2307\/4582686","article-title":"Studies on immunizing substances in pneumococci. VIII. Report on field tests to determine the prophylactic value of a pneumococcus antigen.","volume":"53","author":"Ekwurzel","year":"1938","journal-title":"Public Health Rep"},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.82.6.445","article-title":"Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides.","volume":"82","author":"Macleod","year":"1945","journal-title":"J Exp Med"},{"key":"R19-20230908","first-page":"181","article-title":"Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005.","volume":"31","author":"Skowronski","year":"2005","journal-title":"Can Commun Dis Rep"},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12879-016-1662-4","article-title":"Epidemiological risk factors for adult dengue in Singapore: an 8-year nested test negative case control study.","volume":"16","author":"Yung","year":"2016","journal-title":"BMC Infect Dis"},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/aje\/kwy099","article-title":"Cluster-randomized test-negative design Trials: a novel and efficient method to assess the efficacy of community-level dengue interventions.","volume":"187","author":"Anders","year":"2018","journal-title":"Am J Epidemiol"},{"key":"R22-20230908","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/biostatistics\/kxy005","article-title":"Analysis of cluster-randomized test-negative designs: cluster-level methods.","volume":"20","author":"Jewell","year":"2019","journal-title":"Biostatistics"},{"key":"R23-20230908","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R24-20230908","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/EDE.0b013e31826b300e","article-title":"Virus interference and estimates of influenza vaccine effectiveness from test-negative studies.","volume":"23","author":"Cowling","year":"2012","journal-title":"Epidemiology"},{"key":"R25-20230908","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/aje\/kwx251","article-title":"Estimating influenza vaccine effectiveness in the test-negative design using alternative control groups - a systematic review and meta-analysis.","volume":"187","author":"Feng","year":"2017","journal-title":"Am J Epidemiol"},{"key":"R26-20230908","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/cid\/cis307","article-title":"Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine.","volume":"54","author":"Cowling","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R27-20230908","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.vaccine.2011.11.033","article-title":"Influenza vaccine effectiveness among adult patients in a University of Lyon hospital (2004-2009).","volume":"30","author":"Amour","year":"2012","journal-title":"Vaccine"},{"key":"R28-20230908","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/infdis\/jiq014","article-title":"Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England.","volume":"203","author":"Andrews","year":"2011","journal-title":"J Infect Dis"},{"key":"R29-20230908","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2807\/1560-7917.ES2014.19.27.20851","article-title":"Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012\/13 end of season results.","volume":"19","author":"Andrews","year":"2014","journal-title":"Euro Surveill"},{"key":"R30-20230908","first-page":"39","article-title":"Effectiveness of 2010\/2011 seasonal influenza vaccine in Ireland.","volume":"105","author":"Barret","year":"2012","journal-title":"Ir Med J"},{"key":"R31-20230908","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/infdis\/jit020","article-title":"Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.","volume":"207","author":"Bateman","year":"2013","journal-title":"J Infect Dis"},{"key":"R32-20230908","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/595861","article-title":"Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.","volume":"199","author":"Belongia","year":"2009","journal-title":"J Infect Dis"},{"key":"R33-20230908","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1016\/j.vaccine.2011.07.002","article-title":"Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results.","volume":"29","author":"Belongia","year":"2011","journal-title":"Vaccine"},{"key":"R34-20230908","doi-asserted-by":"crossref","first-page":"e1218","DOI":"10.1542\/peds.2013-3707","article-title":"Effectiveness of trivalent flu vaccine in healthy young children.","volume":"133","author":"Blyth","year":"2014","journal-title":"Pediatrics"},{"key":"R35-20230908","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.vaccine.2010.10.082","article-title":"Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR).","volume":"29","author":"Coleman","year":"2011","journal-title":"Vaccine"},{"key":"R36-20230908","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1016\/j.vaccine.2011.06.063","article-title":"Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.","volume":"29","author":"Castilla","year":"2011","journal-title":"Vaccine"},{"key":"R37-20230908","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.vaccine.2011.11.024","article-title":"Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study.","volume":"30","author":"Castilla","year":"2012","journal-title":"Vaccine"},{"key":"R38-20230908","first-page":"20388","article-title":"Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011\/12.","volume":"18","author":"Castilla","year":"2013","journal-title":"Euro Surveill"},{"key":"R39-20230908","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1016\/j.vaccine.2011.07.087","article-title":"Effectiveness of H1N1\/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1\/09 influenza in Australia: a test-negative case control study.","volume":"29","author":"Cheng","year":"2011","journal-title":"Vaccine"},{"key":"R40-20230908","doi-asserted-by":"crossref","first-page":"e68760","DOI":"10.1371\/journal.pone.0068760","article-title":"Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study.","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"key":"R41-20230908","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1016\/j.vaccine.2014.07.084","article-title":"The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013.","volume":"32","author":"Cowling","year":"2014","journal-title":"Vaccine"},{"key":"R42-20230908","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/irv.12233","article-title":"Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged \u2265 50 years.","volume":"8","author":"Dawood","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"R43-20230908","doi-asserted-by":"crossref","first-page":"e41435","DOI":"10.1371\/journal.pone.0041435","article-title":"Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach.","volume":"7","author":"Eick-Cost","year":"2012","journal-title":"PLoS One"},{"key":"R44-20230908","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1542\/peds.2007-3304","article-title":"Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons.","volume":"122","author":"Eisenberg","year":"2008","journal-title":"Pediatrics"},{"key":"R45-20230908","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1017\/S0950268812002282","article-title":"Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010\/2011 season.","volume":"141","author":"Englund","year":"2013","journal-title":"Epidemiol Infect"},{"key":"R46-20230908","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/infdis\/jiu185","article-title":"Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012.","volume":"210","author":"Ferdinands","year":"2014","journal-title":"J Infect Dis"},{"key":"R47-20230908","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-11-170","article-title":"Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.","volume":"11","author":"Fielding","year":"2011","journal-title":"BMC Infect Dis"},{"key":"R48-20230908","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3201\/eid1707.101959","article-title":"Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.","volume":"17","author":"Fielding","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R49-20230908","doi-asserted-by":"crossref","first-page":"pii=20115","DOI":"10.2807\/ese.17.11.20115-en","article-title":"Moderate influenza vaccine effectiveness in Victoria, Australia, 2011.","volume":"17","author":"Fielding","year":"2012","journal-title":"Euro Surveill"},{"key":"R50-20230908","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/jech.2009.093450","article-title":"Estimating influenza vaccine effectiveness using routinely collected laboratory data.","volume":"64","author":"Fleming","year":"2010","journal-title":"J Epidemiol Community Health"},{"key":"R51-20230908","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.vaccine.2013.12.021","article-title":"Seasonal influenza vaccine effectiveness against influenza in 2012-2013: a hospital-based case-control study in Lithuania.","volume":"32","author":"Gefenaite","year":"2014","journal-title":"Vaccine"},{"key":"R52-20230908","doi-asserted-by":"crossref","first-page":"e23085","DOI":"10.1371\/journal.pone.0023085","article-title":"Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities.","volume":"6","author":"Griffin","year":"2011","journal-title":"PLoS One"},{"key":"R53-20230908","doi-asserted-by":"crossref","first-page":"19763","DOI":"10.2807\/ese.16.02.19763-en","article-title":"Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.","volume":"16","author":"Hardelid","year":"2011","journal-title":"Euro Surveill"},{"key":"R54-20230908","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2334-12-127","article-title":"Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.","volume":"12","author":"Hellenbrand","year":"2012","journal-title":"BMC Infect Dis"},{"key":"R55-20230908","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/irv.12256","article-title":"Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013.","volume":"8","author":"Ho","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"R56-20230908","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/infdis\/jis283","article-title":"Estimates of influenza vaccine effectiveness for 2007-2008 from Canada\u2019s sentinel surveillance system: cross-protection against major and minor variants.","volume":"205","author":"Janjua","year":"2012","journal-title":"J Infect Dis"},{"key":"R57-20230908","doi-asserted-by":"crossref","first-page":"19761","DOI":"10.2807\/ese.16.02.19761-en","article-title":"Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A (H1N1) 2009 in healthcare workers in New Zealand, June-August 2009.","volume":"16","author":"Jefferies","year":"2011","journal-title":"Euro Surveill"},{"key":"R58-20230908","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1016\/j.vaccine.2012.03.048","article-title":"Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.","volume":"30","author":"Jim\u00e9nez-Jorge","year":"2012","journal-title":"Vaccine"},{"key":"R59-20230908","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1471-2334-13-441","article-title":"Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.","volume":"13","author":"Jim\u00e9nez-Jorge","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R60-20230908","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/irv.12163","article-title":"Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010\/2011 season: a primary care-based cohort study.","volume":"7","author":"Kafatos","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"R61-20230908","doi-asserted-by":"crossref","first-page":"e5079","DOI":"10.1371\/journal.pone.0005079","article-title":"Estimation of influenza vaccine effectiveness from routine surveillance data.","volume":"4","author":"Kelly","year":"2009","journal-title":"PLoS One"},{"key":"R62-20230908","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1016\/j.vaccine.2011.03.055","article-title":"Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009.","volume":"29","author":"Kelly","year":"2011","journal-title":"Vaccine"},{"key":"R63-20230908","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/INF.0b013e318201811c","article-title":"Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-Control Study.","volume":"30","author":"Kelly","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R64-20230908","doi-asserted-by":"crossref","first-page":"19388","DOI":"10.2807\/ese.14.44.19388-en","article-title":"\u201cI-MOVE\u201d towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case\u2013control study in Europe, 2008-9.","volume":"14","author":"Kissling","year":"2009","journal-title":"Euro Surveill"},{"key":"R65-20230908","doi-asserted-by":"crossref","first-page":"e27622","DOI":"10.1371\/journal.pone.0027622","article-title":"I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.","volume":"6","author":"Kissling","year":"2011","journal-title":"PLoS One"},{"key":"R66-20230908","doi-asserted-by":"crossref","first-page":"20390","DOI":"10.2807\/ese.18.05.20390-en","article-title":"Low and decreasing vaccine effectiveness against influenza A(H3) in 2011\/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case\u2013control study.","volume":"18","author":"Kissling","year":"2013","journal-title":"Euro Surveill"},{"key":"R67-20230908","doi-asserted-by":"crossref","first-page":"20701","DOI":"10.2807\/1560-7917.ES2014.19.6.20701","article-title":"Influenza vaccine effectiveness estimates in Europe in a season with three influenza type\/subtypes circulating: the I-MOVE multicentre case\u2013control study, influenza season 2012\/13.","volume":"19","author":"Kissling","year":"2014","journal-title":"Euro Surveill"},{"key":"R68-20230908","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/cid\/cit404","article-title":"Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season.","volume":"57","author":"Kwong","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R69-20230908","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gaceta.2010.06.010","article-title":"Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain.","volume":"25","author":"Larrauri","year":"2011","journal-title":"Gac Sanit"},{"key":"R70-20230908","doi-asserted-by":"crossref","first-page":"e58222","DOI":"10.1371\/journal.pone.0058222","article-title":"Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B\/Yamagata-lineage viruses in Taiwan, 2011-12 season.","volume":"8","author":"Lo","year":"2013","journal-title":"PLoS One"},{"key":"R71-20230908","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1016\/j.vaccine.2011.08.068","article-title":"Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.","volume":"29","author":"Mahmud","year":"2011","journal-title":"Vaccine"},{"key":"R72-20230908","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3201\/eid1805.111596","article-title":"No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009.","volume":"18","author":"Mahmud","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"R73-20230908","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2458-13-191","article-title":"Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study.","volume":"13","author":"Mart\u00ednez-Baz","year":"2013","journal-title":"BMC Public Health"},{"key":"R74-20230908","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1016\/j.vaccine.2014.06.048","article-title":"Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy.","volume":"32","author":"Menniti-Ippolito","year":"2014","journal-title":"Vaccine"},{"key":"R75-20230908","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1016\/j.vaccine.2014.06.053","article-title":"Estimates of 2012\/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups.","volume":"32","author":"Nunes","year":"2014","journal-title":"Vaccine"},{"key":"R76-20230908","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cid\/cit736","article-title":"Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.","volume":"58","author":"Ohmit","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R77-20230908","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1016\/j.vaccine.2012.07.009","article-title":"Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.","volume":"30","author":"Ortqvist","year":"2012","journal-title":"Vaccine"},{"key":"R78-20230908","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.vaccine.2011.01.046","article-title":"No effect of 2008\/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.","volume":"29","author":"Pebody","year":"2011","journal-title":"Vaccine"},{"key":"R79-20230908","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1017\/S0950268812001148","article-title":"Age-specific vaccine effectiveness of seasonal 2010\/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.","volume":"141","author":"Pebody","year":"2013","journal-title":"Epidemiol Infect"},{"key":"R80-20230908","doi-asserted-by":"crossref","first-page":"20389","DOI":"10.2807\/ese.18.05.20389-en","article-title":"Vaccine effectiveness of 2011\/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.","volume":"18","author":"Pebody","year":"2013","journal-title":"Euro Surveill"},{"key":"R81-20230908","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1016\/j.vaccine.2010.09.042","article-title":"Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case\u2013control study.","volume":"28","author":"Puig-Barbera","year":"2010","journal-title":"Vaccine"},{"key":"R82-20230908","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1016\/j.vaccine.2012.07.006","article-title":"Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study.","volume":"30","author":"Puig-Barber\u00e0","year":"2012","journal-title":"Vaccine"},{"key":"R83-20230908","doi-asserted-by":"crossref","first-page":"e100497","DOI":"10.1371\/journal.pone.0100497","article-title":"2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network.","volume":"9","author":"Puig-Barber\u00e0","year":"2014","journal-title":"PLoS One"},{"key":"R84-20230908","doi-asserted-by":"crossref","first-page":"e59681","DOI":"10.1371\/journal.pone.0059681","article-title":"2011-12 seasonal influenza vaccines effectiveness against confirmed A(H3N2) influenza hospitalisation: pooled analysis from a European network of hospitals. A pilot study.","volume":"8","author":"Rondy","year":"2013","journal-title":"PLoS One"},{"key":"R85-20230908","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.vaccine.2010.01.054","article-title":"Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network\u2013pilot case-control studies using different control groups, 2008-2009 season, Spain.","volume":"28","author":"Savulescu","year":"2010","journal-title":"Vaccine"},{"key":"R86-20230908","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1186\/1471-2458-11-899","article-title":"Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.","volume":"11","author":"Savulescu","year":"2011","journal-title":"BMC Public Health"},{"key":"R87-20230908","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/j.vaccine.2014.06.063","article-title":"Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.","volume":"32","author":"Savulescu","year":"2014","journal-title":"Vaccine"},{"key":"R88-20230908","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.vaccine.2006.10.002","article-title":"Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.","volume":"25","author":"Skowronski","year":"2007","journal-title":"Vaccine"},{"key":"R89-20230908","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/595862","article-title":"Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.","volume":"199","author":"Skowronski","year":"2009","journal-title":"J Infect Dis"},{"key":"R90-20230908","doi-asserted-by":"crossref","first-page":"e1000258","DOI":"10.1371\/journal.pmed.1000258","article-title":"Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.","volume":"7","author":"Skowronski","year":"2010","journal-title":"PLoS Med"},{"key":"R91-20230908","doi-asserted-by":"crossref","first-page":"c7297","DOI":"10.1136\/bmj.c7297","article-title":"Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.","volume":"342","author":"Skowronski","year":"2011","journal-title":"BMJ"},{"key":"R92-20230908","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/cis431","article-title":"A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.","volume":"55","author":"Skowronski","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R93-20230908","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/infdis\/jiu048","article-title":"Influenza A\/subtype and B\/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.","volume":"210","author":"Skowronski","year":"2014","journal-title":"J Infect Dis"},{"key":"R94-20230908","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.vaccine.2010.12.050","article-title":"Effectiveness of the pandemic influenza A\/H1N1 2009 monovalent vaccine in Korea.","volume":"29","author":"Song","year":"2011","journal-title":"Vaccine"},{"key":"R95-20230908","doi-asserted-by":"crossref","first-page":"9005","DOI":"10.1016\/j.vaccine.2011.09.037","article-title":"Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007.","volume":"29","author":"Staat","year":"2011","journal-title":"Vaccine"},{"key":"R96-20230908","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jmv.23847","article-title":"Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match.","volume":"86","author":"Sullivan","year":"2014","journal-title":"J Med Virol"},{"key":"R97-20230908","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5694\/mja14.00106","article-title":"Influenza vaccine effectiveness in Australia: results from the Australian sentinel practices research network.","volume":"201","author":"Sullivan","year":"2014","journal-title":"Med J Aust"},{"key":"R98-20230908","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/cid\/cit379","article-title":"Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness.","volume":"57","author":"Sundaram","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R99-20230908","doi-asserted-by":"crossref","first-page":"e52103","DOI":"10.1371\/journal.pone.0052103","article-title":"Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan.","volume":"8","author":"Suzuki","year":"2013","journal-title":"PLoS One"},{"key":"R100-20230908","doi-asserted-by":"crossref","first-page":"e88813","DOI":"10.1371\/journal.pone.0088813","article-title":"Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011-2012 Season.","volume":"9","author":"Suzuki","year":"2014","journal-title":"PLoS One"},{"key":"R101-20230908","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/infdis\/jiq076","article-title":"Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults.","volume":"203","author":"Talbot","year":"2011","journal-title":"J Infect Dis"},{"key":"R102-20230908","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/cid\/cit124","article-title":"Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season.","volume":"56","author":"Talbot","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R103-20230908","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cid\/cit750","article-title":"Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.","volume":"58","author":"Thompson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R104-20230908","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/cis574","article-title":"Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.","volume":"55","author":"Treanor","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R105-20230908","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1016\/j.vaccine.2014.04.013","article-title":"The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012.","volume":"32","author":"Turner","year":"2014","journal-title":"Vaccine"},{"key":"R106-20230908","doi-asserted-by":"crossref","first-page":"e19932","DOI":"10.1371\/journal.pone.0019932","article-title":"Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A\/(H1N1) 2009\u2013a comparison of two methods; Germany, 2009\/10.","volume":"6","author":"Uphoff","year":"2011","journal-title":"PLoS One"},{"key":"R107-20230908","doi-asserted-by":"crossref","first-page":"e1000388","DOI":"10.1371\/journal.pmed.1000388","article-title":"Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.","volume":"8","author":"Valenciano","year":"2011","journal-title":"PLoS Med"},{"key":"R108-20230908","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1750-2659.2010.00146.x","article-title":"Protective effect of single-dose adjuvanted pandemic influenza vaccine in children.","volume":"4","author":"Van Buynder","year":"2010","journal-title":"Influenza Other Respir Viruses"},{"key":"R109-20230908","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1016\/j.vaccine.2013.07.059","article-title":"The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly.","volume":"31","author":"Van Buynder","year":"2013","journal-title":"Vaccine"},{"key":"R110-20230908","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1016\/j.vaccine.2014.07.083","article-title":"Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.","volume":"32","author":"Yang","year":"2014","journal-title":"Vaccine"},{"key":"R111-20230908","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1016\/j.vaccine.2009.05.038","article-title":"Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study.","volume":"27","author":"Joshi","year":"2009","journal-title":"Vaccine"},{"key":"R112-20230908","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/657309","article-title":"Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants.","volume":"51","author":"Benowitz","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R113-20230908","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4161\/hv.6.9.12470","article-title":"Vaccine effectiveness against laboratory-confirmed influenza in infants: a matched case control study.","volume":"6","author":"Cochran","year":"2010","journal-title":"Hum Vaccin"},{"key":"R114-20230908","doi-asserted-by":"crossref","first-page":"e000167","DOI":"10.1136\/bmjopen-2011-000167","article-title":"Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case\u2013control study.","volume":"1","author":"Menniti-Ippolito","year":"2011","journal-title":"BMJ Open"},{"key":"R115-20230908","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2011.00296.x","article-title":"The post-infection outcomes of influenza and acute respiratory infection in patients above 50 years of age in Japan: an observational study.","volume":"6","author":"Ikematsu","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"key":"R116-20230908","doi-asserted-by":"crossref","first-page":"20397","DOI":"10.2807\/ese.18.06.20397-en","article-title":"Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012\/13--a rapid epidemiological and virological assessment.","volume":"18","author":"Bragstad","year":"2013","journal-title":"Euro Surveill"},{"key":"R117-20230908","first-page":"E246","article-title":"Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN).","volume":"37","author":"Cheng","year":"2013","journal-title":"Commun Dis Intell Q Rep"},{"key":"R118-20230908","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/CVI.00009-13","article-title":"Case-control study of the effectiveness of the 2010-2011 seasonal influenza vaccine for prevention of laboratory-confirmed influenza virus infection in the Korean adult population.","volume":"20","author":"Choi","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"R119-20230908","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1016\/j.vaccine.2013.07.056","article-title":"Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method\u2013experience across the 2010\/11 season.","volume":"31","author":"Kavanagh","year":"2013","journal-title":"Vaccine"},{"key":"R120-20230908","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/irv.12018","article-title":"Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.","volume":"7","author":"Kelly","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"R121-20230908","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.vaccine.2013.01.022","article-title":"Mid-season influenza vaccine effectiveness 2011-2012: a department of defense global, laboratory-based, influenza surveillance system case-control study estimate.","volume":"31","author":"MacIntosh","year":"2013","journal-title":"Vaccine"},{"key":"R122-20230908","doi-asserted-by":"crossref","first-page":"e63156","DOI":"10.1371\/journal.pone.0063156","article-title":"Effectiveness of MF59\u2122 adjuvanted influenza A(H1N1)pdm09 vaccine in risk groups in the Netherlands.","volume":"8","author":"Wijnans","year":"2013","journal-title":"PLoS One"},{"key":"R123-20230908","first-page":"E143","article-title":"Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the influenza complications alert network.","volume":"38","author":"Cheng","year":"2014","journal-title":"Commun Dis Intell Q Rep"},{"key":"R124-20230908","first-page":"15","article-title":"Brief report: mid-season influenza vaccine effectiveness estimates for the 2013-2014 influenza season.","volume":"21","author":"Cost","year":"2014","journal-title":"MSMR"},{"key":"R125-20230908","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4161\/hv.27490","article-title":"Effectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: a case control study.","volume":"10","author":"Kulkarni","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R126-20230908","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1016\/j.vaccine.2014.08.066","article-title":"Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012.","volume":"32","author":"Levy","year":"2014","journal-title":"Vaccine"},{"key":"R127-20230908","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.gaceta.2013.09.007","article-title":"Influence of distinct criteria for selecting patients for swabbing on estimation of the effectiveness of the influenza vaccine.","volume":"28","author":"Mart\u00ednez-Baz","year":"2014","journal-title":"Gac Sanit"},{"key":"R128-20230908","doi-asserted-by":"crossref","first-page":"20729","DOI":"10.2807\/1560-7917.ES2014.19.9.20729","article-title":"Interim estimates of 2013\/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.","volume":"19","author":"McNeil","year":"2014","journal-title":"Euro Surveill"},{"key":"R129-20230908","doi-asserted-by":"crossref","first-page":"e112294","DOI":"10.1371\/journal.pone.0112294","article-title":"Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain.","volume":"9","author":"Puig-Barber\u00e0","year":"2014","journal-title":"PLoS One"},{"key":"R130-20230908","doi-asserted-by":"crossref","first-page":"e92153","DOI":"10.1371\/journal.pone.0092153","article-title":"Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.","volume":"9","author":"Skowronski","year":"2014","journal-title":"PLoS One"},{"key":"R131-20230908","first-page":"20884","article-title":"Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013.","volume":"19","author":"Turner","year":"2014","journal-title":"Euro Surveill"},{"key":"R132-20230908","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vaccine.2014.06.052","article-title":"Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season.","volume":"33","author":"Belongia","year":"2015","journal-title":"Vaccine"},{"key":"R133-20230908","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1016\/j.vaccine.2015.10.122","article-title":"The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia.","volume":"33","author":"Blyth","year":"2015","journal-title":"Vaccine"},{"key":"R134-20230908","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.vaccine.2014.11.019","article-title":"Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.","volume":"33","author":"Carville","year":"2015","journal-title":"Vaccine"},{"key":"R135-20230908","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/infdis\/jiu578","article-title":"Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged \u226550 years.","volume":"211","author":"Chen","year":"2015","journal-title":"J Infect Dis"},{"key":"R136-20230908","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1016\/j.vaccine.2015.10.016","article-title":"Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014.","volume":"33","author":"Cheng","year":"2015","journal-title":"Vaccine"},{"key":"R137-20230908","doi-asserted-by":"crossref","first-page":"e0098716","DOI":"10.1371\/journal.pone.0098716","article-title":"Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult Korean populations.","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS One"},{"key":"R138-20230908","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1186\/s12889-015-2001-1","article-title":"Pilot to evaluate the feasibility of measuring seasonal influenza vaccine effectiveness using surveillance platforms in Central-America, 2012.","volume":"15","author":"El Omeiri","year":"2015","journal-title":"BMC Public Health"},{"key":"R139-20230908","doi-asserted-by":"crossref","first-page":"e0132195","DOI":"10.1371\/journal.pone.0132195","article-title":"Mid-season estimates of influenza vaccine effectiveness against influenza A(H3N2) hospitalization in the elderly in Quebec, Canada, January 2015.","volume":"10","author":"Gilca","year":"2015","journal-title":"PLoS One"},{"key":"R140-20230908","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2015.12160","article-title":"Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination.","volume":"314","author":"Grijalva","year":"2015","journal-title":"JAMA"},{"key":"R141-20230908","doi-asserted-by":"crossref","first-page":"e0122910","DOI":"10.1371\/journal.pone.0122910","article-title":"Effectiveness of the 2012\/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study.","volume":"10","author":"Helmeke","year":"2015","journal-title":"PLoS One"},{"key":"R142-20230908","doi-asserted-by":"crossref","first-page":"21187","DOI":"10.2807\/1560-7917.ES2015.20.28.21187","article-title":"Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data.","volume":"20","author":"Jimenez-Jorge","year":"2015","journal-title":"Euro Surveill"},{"key":"R143-20230908","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1016\/j.vaccine.2015.03.051","article-title":"Interim influenza vaccine effectiveness: a good proxy for final estimates in Spain in the seasons 2010-2014.","volume":"33","author":"Jim\u00e9nez-Jorge","year":"2015","journal-title":"Vaccine"},{"key":"R144-20230908","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1017\/S0950268814003677","article-title":"Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus.","volume":"143","author":"Kure\u010di\u0107 Filipovi\u0107","year":"2015","journal-title":"Epidemiol Infect"},{"key":"R145-20230908","doi-asserted-by":"crossref","first-page":"e0134318","DOI":"10.1371\/journal.pone.0134318","article-title":"Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.","volume":"10","author":"Levy","year":"2015","journal-title":"PLoS One"},{"key":"R146-20230908","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.vaccine.2014.11.005","article-title":"Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.","volume":"33","author":"Lytras","year":"2015","journal-title":"Vaccine"},{"key":"R147-20230908","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1080\/21645515.2015.1038002","article-title":"Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.","volume":"11","author":"Mart\u00ednez-Baz","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R148-20230908","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/irv.12314","article-title":"Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014.","volume":"9","author":"McAnerney","year":"2015","journal-title":"Influenza Other Respir Viruses"},{"key":"R149-20230908","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/irv.12305","article-title":"Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013.","volume":"9","author":"McAnerney","year":"2015","journal-title":"Influenza Other Respir Viruses"},{"key":"R150-20230908","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiu647","article-title":"Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.","volume":"211","author":"McLean","year":"2015","journal-title":"J Infect Dis"},{"key":"R151-20230908","doi-asserted-by":"crossref","first-page":"21024","DOI":"10.2807\/1560-7917.ES2015.20.5.21024","article-title":"Interim estimates of 2014\/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the serious outcomes surveillance network of the Canadian Immunization Research Network, January 2015.","volume":"20","author":"McNeil","year":"2015","journal-title":"Euro Surveill"},{"key":"R152-20230908","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.vaccine.2015.04.011","article-title":"Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.","volume":"33","author":"\u00d6rtqvist","year":"2015","journal-title":"Vaccine"},{"key":"R153-20230908","first-page":"30013","article-title":"Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014\/15 end of season results.","volume":"20","author":"Pebody","year":"2015","journal-title":"Euro Surveill"},{"key":"R154-20230908","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.2807\/1560-7917.ES2015.20.2.21011","article-title":"2012\/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.","volume":"20","author":"Rondy","year":"2015","journal-title":"Euro Surveill"},{"key":"R155-20230908","doi-asserted-by":"crossref","first-page":"21100","DOI":"10.2807\/1560-7917.ES2015.20.16.21100","article-title":"Strengths and limitations of assessing influenza vaccine effectiveness using routinely collected, passive surveillance data in Ontario, Canada, 2007 to 2012: balancing efficiency versus quality.","volume":"20","author":"Savage","year":"2015","journal-title":"Euro Surveill"},{"key":"R156-20230908","doi-asserted-by":"crossref","first-page":"e0136539","DOI":"10.1371\/journal.pone.0136539","article-title":"Effectiveness of trivalent inactivated influenza vaccine in children estimated by a test-negative case-control design study based on influenza rapid diagnostic test results.","volume":"10","author":"Shinjoh","year":"2015","journal-title":"PLoS One"},{"key":"R157-20230908","doi-asserted-by":"crossref","first-page":"21043","DOI":"10.2807\/1560-7917.ES2015.20.8.21043","article-title":"Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009.","volume":"20","author":"Simpson","year":"2015","journal-title":"Euro Surveill"},{"key":"R158-20230908","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijid.2014.11.011","article-title":"Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6-59 months for five consecutive influenza seasons.","volume":"30","author":"Su","year":"2015","journal-title":"Int J Infect Dis"},{"key":"R159-20230908","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/cid\/civ019","article-title":"Clinical effectiveness of split-virion versus subunit trivalent influenza vaccines in older adults.","volume":"60","author":"Talbot","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R160-20230908","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4161\/hv.36155","article-title":"Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons.","volume":"11","author":"Torner","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R161-20230908","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.vaccine.2015.04.012","article-title":"The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).","volume":"33","author":"Valenciano","year":"2015","journal-title":"Vaccine"},{"key":"R162-20230908","doi-asserted-by":"crossref","first-page":"30101","DOI":"10.2807\/1560-7917.ES.2016.21.1.30101","article-title":"Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates.","volume":"21","author":"Bissielo","year":"2016","journal-title":"Euro Surveill"},{"key":"R163-20230908","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/INF.0000000000000999","article-title":"Influenza vaccine effectiveness and uptake in children at risk of severe disease.","volume":"35","author":"Blyth","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R164-20230908","doi-asserted-by":"crossref","first-page":"30301","DOI":"10.2807\/1560-7917.ES.2016.21.30.30301","article-title":"Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).","volume":"21","author":"Blyth","year":"2016","journal-title":"Euro Surveill"},{"key":"R165-20230908","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1016\/j.vaccine.2016.08.079","article-title":"Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States.","volume":"34","author":"Caspard","year":"2016","journal-title":"Vaccine"},{"key":"R166-20230908","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vaccine.2015.11.010","article-title":"Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.","volume":"34","author":"Caspard","year":"2016","journal-title":"Vaccine"},{"key":"R167-20230908","first-page":"30243","article-title":"Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013\/14 season.","volume":"20","author":"Castilla","year":"2016","journal-title":"Euro Surveill"},{"key":"R168-20230908","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.vaccine.2016.01.054","article-title":"Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.","volume":"34","author":"Castilla","year":"2016","journal-title":"Vaccine"},{"key":"R169-20230908","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.vaccine.2016.03.032","article-title":"Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.","volume":"34","author":"Chiu","year":"2016","journal-title":"Vaccine"},{"key":"R170-20230908","doi-asserted-by":"crossref","first-page":"30189","DOI":"10.2807\/1560-7917.ES.2016.21.14.30189","article-title":"Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015\/16 - a rapid epidemiological and virological assessment.","volume":"21","author":"Emborg","year":"2016","journal-title":"Euro Surveill"},{"key":"R171-20230908","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1016\/j.vaccine.2016.08.067","article-title":"Effectiveness of seasonal influenza vaccine in Australia, 2015: an epidemiological, antigenic and phylogenetic assessment.","volume":"34","author":"Fielding","year":"2016","journal-title":"Vaccine"},{"key":"R172-20230908","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/infdis\/jiw181","article-title":"Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015.","volume":"214","author":"Flannery","year":"2016","journal-title":"J Infect Dis"},{"key":"R173-20230908","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/infdis\/jiv577","article-title":"Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013-2014 in the United States.","volume":"213","author":"Gaglani","year":"2016","journal-title":"J Infect Dis"},{"key":"R174-20230908","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2016.03.035","article-title":"Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.","volume":"34","author":"Gherasim","year":"2016","journal-title":"Vaccine"},{"key":"R175-20230908","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/INF.0000000000001035","article-title":"Uptake and effectiveness of a trivalent inactivated influenza vaccine in children in Urban and Rural Kenya, 2010 to 2012.","volume":"35","author":"Katz","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R176-20230908","doi-asserted-by":"crossref","first-page":"76.e1","DOI":"10.5694\/mja15.01017","article-title":"Influenza vaccine effectiveness in general practice and in hospital patients in Victoria, 2011-2013.","volume":"204","author":"Kelly","year":"2016","journal-title":"Med J Aust"},{"key":"R177-20230908","first-page":"30201","article-title":"I-MOVE multicentre case\u2013control study 2010\/11 to 2014\/15: is there within-season waning of influenza type\/subtype vaccine effectiveness with increasing time since vaccination?","volume":"21","author":"Kissling","year":"2016","journal-title":"Euro Surveill"},{"key":"R178-20230908","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1097\/INF.0000000000001280","article-title":"Effectiveness of the 2013 and 2014 Southern Hemisphere influenza vaccines against laboratory-confirmed influenza in young children using a test-negative design, Bangkok, Thailand.","volume":"35","author":"Kittikraisak","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R179-20230908","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.vaccine.2016.01.002","article-title":"Seasonal influenza vaccine effectiveness estimates: development of a parsimonious case test negative model using a causal approach.","volume":"34","author":"Lane","year":"2016","journal-title":"Vaccine"},{"key":"R180-20230908","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/jmv.24551","article-title":"Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: a test-negative study.","volume":"88","author":"Lytras","year":"2016","journal-title":"J Med Virol"},{"key":"R181-20230908","first-page":"30348","article-title":"Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015\/16 end-of-season results.","volume":"21","author":"Pebody","year":"2016","journal-title":"Euro Surveill"},{"key":"R182-20230908","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/ciw432","article-title":"Influenza vaccine effectiveness against antigenically drifted influenza higher than expected in hospitalized adults: 2014-2015.","volume":"63","author":"Petrie","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R183-20230908","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.vaccine.2015.11.073","article-title":"Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014.","volume":"34","author":"Pierse","year":"2016","journal-title":"Vaccine"},{"key":"R184-20230908","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.vaccine.2016.03.068","article-title":"Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15.","volume":"34","author":"Qin","year":"2016","journal-title":"Vaccine"},{"key":"R185-20230908","doi-asserted-by":"crossref","first-page":"e0149916","DOI":"10.1371\/journal.pone.0149916","article-title":"Detailed report on 2014\/15 influenza virus characteristics, and estimates on influenza virus vaccine effectiveness from Austria\u2019s sentinel physician surveillance network.","volume":"11","author":"Redlberger-Fritz","year":"2016","journal-title":"PLoS One"},{"key":"R186-20230908","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.vaccine.2016.04.072","article-title":"Influenza vaccine effectiveness in Italy: age, subtype-specific and vaccine type estimates 2014\/15 season.","volume":"34","author":"Rizzo","year":"2016","journal-title":"Vaccine"},{"key":"R187-20230908","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/21645515.2015.1126013","article-title":"Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: results from the InNHOVE network.","volume":"12","author":"Rondy","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"R188-20230908","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cid\/ciw176","article-title":"A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014-2015 season.","volume":"63","author":"Skowronski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R189-20230908","doi-asserted-by":"crossref","first-page":"30377","DOI":"10.2807\/1560-7917.ES.2016.21.42.30377","article-title":"Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014\/15 season, Japan.","volume":"21","author":"Sugaya","year":"2016","journal-title":"Euro Surveill"},{"key":"R190-20230908","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.vaccine.2016.02.037","article-title":"Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.","volume":"34","author":"Talbot","year":"2016","journal-title":"Vaccine"},{"key":"R191-20230908","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/INF.0000000000001006","article-title":"Influenza vaccine effectiveness for fully and partially vaccinated children 6 months to 8 years old during 2011-2012 and 2012-2013: the importance of two priming doses.","volume":"35","author":"Thompson","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R192-20230908","doi-asserted-by":"crossref","first-page":"30139","DOI":"10.2807\/1560-7917.ES.2016.21.7.30139","article-title":"Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case\u2013control Study, Europe 2014\/15.","volume":"21","author":"Valenciano","year":"2016","journal-title":"Euro Surveill"},{"key":"R193-20230908","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/21645515.2015.1079677","article-title":"Influenza vaccine effectiveness among healthcare workers in comparison to hospitalized patients: a 2004-2009 case-test, negative-control, prospective study.","volume":"12","author":"Vanhems","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"R194-20230908","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.vaccine.2016.03.056","article-title":"Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: a matched test-negative case-control study in Suzhou, China.","volume":"34","author":"Wang","year":"2016","journal-title":"Vaccine"},{"key":"R195-20230908","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014-2015 influenza vaccine effectiveness in the United States by Vaccine Type.","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R196-20230908","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/jix282","article-title":"The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people.","volume":"216","author":"Andrew","year":"2017","journal-title":"J Infect Dis"},{"key":"R197-20230908","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/cix209","article-title":"Repeated vaccination does not appear to impact upon influenza vaccine effectiveness against hospitalization with confirmed influenza.","volume":"64","author":"Cheng","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R198-20230908","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/irv.12399","article-title":"Interim estimates of the effectiveness of influenza vaccination against influenza-associated hospitalization in children in Hong Kong, 2015-16.","volume":"11","author":"Cowling","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"key":"R199-20230908","doi-asserted-by":"crossref","first-page":"e0169528","DOI":"10.1371\/journal.pone.0169528","article-title":"Influenza vaccine effectiveness in the Netherlands from 2003\/2004 through 2013\/2014: the importance of circulating influenza virus types and subtypes.","volume":"12","author":"Darvishian","year":"2017","journal-title":"PLoS One"},{"key":"R200-20230908","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1016\/j.vaccine.2017.06.036","article-title":"Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.","volume":"36","author":"El Omeiri","year":"2018","journal-title":"Vaccine"},{"key":"R201-20230908","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/EDE.0000000000000670","article-title":"Assessment of virus interference in a test-negative Study of influenza vaccine effectiveness.","volume":"28","author":"Feng","year":"2017","journal-title":"Epidemiology"},{"key":"R202-20230908","first-page":"544","article-title":"Intraseason waning of influenza vaccine protection: evidence from the US influenza vaccine effectiveness network, 2011-12 through 2014-15.","volume":"64","author":"Ferdinands","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R203-20230908","doi-asserted-by":"crossref","first-page":"e0179160","DOI":"10.1371\/journal.pone.0179160","article-title":"Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain.","volume":"12","author":"Gherasim","year":"2017","journal-title":"PLoS One"},{"key":"R204-20230908","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4274\/balkanmedj.2017.0487","article-title":"Seasonal influenza vaccine effectiveness in preventing laboratory confirmed influenza in 2014-2015 season in Turkey: a test-negative case control Study.","volume":"35","author":"Hekimo\u011flu","year":"2018","journal-title":"Balkan Med J"},{"key":"R205-20230908","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1700153","article-title":"Influenza vaccine effectiveness in the United States during the 2015-2016 Season.","volume":"377","author":"Jackson","year":"2017","journal-title":"N Engl J Med"},{"key":"R206-20230908","doi-asserted-by":"crossref","first-page":"e017835","DOI":"10.1136\/bmjopen-2017-017835","article-title":"Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza in 2015-2016: a hospital-based test-negative case-control study in Lithuania.","volume":"7","author":"Kuliese","year":"2017","journal-title":"BMJ Open"},{"key":"R207-20230908","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1080\/21645515.2017.1359364","article-title":"Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014\/15 season.","volume":"13","author":"Ma","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"R208-20230908","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/infdis\/jix055","article-title":"Effect of repeated vaccination with the same vaccine component against 2009 pandemic influenza A(H1N1) virus.","volume":"215","author":"Mart\u00ednez-Baz","year":"2017","journal-title":"J Infect Dis"},{"key":"R209-20230908","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/irv.12436","article-title":"Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015.","volume":"11","author":"McAnerney","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"key":"R210-20230908","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.vaccine.2017.03.085","article-title":"Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.","volume":"35","author":"McLean","year":"2017","journal-title":"Vaccine"},{"key":"R211-20230908","doi-asserted-by":"crossref","first-page":"e0178010","DOI":"10.1371\/journal.pone.0178010","article-title":"Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season.","volume":"12","author":"Noh","year":"2017","journal-title":"PLoS One"},{"key":"R212-20230908","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/5584_2017_69","article-title":"Vaccine Effectiveness against influenza in 2015\/16 in hospital and ambulatory medical care facilities: polish results of the European I-MOVE+ Multicenter Study.","volume":"1023","author":"Paradowska-Stankiewicz","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"R213-20230908","doi-asserted-by":"crossref","first-page":"pii=1700306","DOI":"10.2807\/1560-7917.ES.2017.22.44.17-00306","article-title":"End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016\/17.","volume":"22","author":"Pebody","year":"2017","journal-title":"Euro Surveill"},{"key":"R214-20230908","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/cid\/cix869","article-title":"2015-2016 vaccine effectiveness of live attenuated and inactivated influenza vaccines in children in the United States.","volume":"66","author":"Poehling","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R215-20230908","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1016\/j.vaccine.2017.09.035","article-title":"Waning protection of influenza vaccination during four influenza seasons, 2011\/2012 to 2014\/2015.","volume":"35","author":"Puig-Barber\u00e0","year":"2017","journal-title":"Vaccine"},{"key":"R216-20230908","doi-asserted-by":"crossref","first-page":"30580","DOI":"10.2807\/1560-7917.ES.2017.22.30.30580","article-title":"2015\/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.","volume":"22","author":"Rondy","year":"2017","journal-title":"Euro Surveill"},{"key":"R217-20230908","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1016\/j.vaccine.2017.06.088","article-title":"Repeated seasonal influenza vaccination among elderly in Europe: effects on laboratory confirmed hospitalised influenza.","volume":"35","author":"Rondy","year":"2017","journal-title":"Vaccine"},{"key":"R218-20230908","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.vaccine.2016.11.024","article-title":"Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: a test-negative case-control study in Japan.","volume":"35","author":"Saito","year":"2017","journal-title":"Vaccine"},{"key":"R219-20230908","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jiac.2017.06.004","article-title":"Influenza vaccine effectiveness in adults based on the rapid influenza diagnostic test results, during the 2015\/16 season.","volume":"23","author":"Seki","year":"2017","journal-title":"J Infect Chemother"},{"key":"R220-20230908","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/infdis\/jix074","article-title":"Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.","volume":"215","author":"Skowronski","year":"2017","journal-title":"J Infect Dis"},{"key":"R221-20230908","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jix526","article-title":"Beyond antigenic match: possible agent-host and immuno-epidemiological influences on influenza vaccine effectiveness during the 2015-2016 Season in Canada.","volume":"216","author":"Skowronski","year":"2017","journal-title":"J Infect Dis"},{"key":"R222-20230908","doi-asserted-by":"crossref","first-page":"30460","DOI":"10.2807\/1560-7917.ES.2017.22.6.30460","article-title":"Interim estimates of 2016\/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.","volume":"22","author":"Skowronski","year":"2017","journal-title":"Euro Surveill"},{"key":"R223-20230908","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2017.08.002","article-title":"Early estimates of 2016\/17 seasonal influenza vaccine effectiveness in primary care in France.","volume":"95","author":"Souty","year":"2017","journal-title":"J Clin Virol"},{"key":"R224-20230908","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2017.06.007","article-title":"Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016\/17 season in Denmark.","volume":"94","author":"Trebbien","year":"2017","journal-title":"J Clin Virol"},{"key":"R225-20230908","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1016\/j.vaccine.2017.06.050","article-title":"Influenza vaccines effectiveness 2013-14 through 2015-16, a test-negative study in children.","volume":"35","author":"Valdin","year":"2017","journal-title":"Vaccine"},{"key":"R226-20230908","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.vaccine.2017.04.012","article-title":"Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: the test-negative design case-control study with different control groups.","volume":"35","author":"van Doorn","year":"2017","journal-title":"Vaccine"},{"key":"R227-20230908","doi-asserted-by":"crossref","first-page":"431.e5","DOI":"10.1016\/j.cmi.2017.09.003","article-title":"Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method.","volume":"24","author":"Vilcu","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"R228-20230908","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.vaccine.2017.03.084","article-title":"Influenza vaccine effectiveness against influenza-associated hospitalization in 2015\/16 season, Beijing, China.","volume":"35","author":"Zhang","year":"2017","journal-title":"Vaccine"},{"key":"R229-20230908","doi-asserted-by":"crossref","first-page":"e0193050","DOI":"10.1371\/journal.pone.0193050","article-title":"Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period.","volume":"13","author":"Anderson","year":"2018","journal-title":"PLoS One"},{"key":"R230-20230908","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1186\/s12879-017-2905-8","article-title":"Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.","volume":"17","author":"Andrew","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R231-20230908","doi-asserted-by":"crossref","first-page":"e0187834","DOI":"10.1371\/journal.pone.0187834","article-title":"Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.","volume":"12","author":"Buchan","year":"2017","journal-title":"PLoS One"},{"key":"R232-20230908","first-page":"pii=1600780","article-title":"Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010\/11 to 2015\/16.","author":"Castilla","year":"2018","journal-title":"Euro Surveill"},{"key":"R233-20230908","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/infdis\/jiy027","article-title":"Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a Prolonged Season, 2016\/2017.","volume":"217","author":"Chiu","year":"2018","journal-title":"J Infect Dis"},{"key":"R234-20230908","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/infdis\/jix634","article-title":"Influence of birth cohort on effectiveness of 2015-2016 influenza vaccine against medically attended illness due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.","volume":"218","author":"Flannery","year":"2018","journal-title":"J Infect Dis"},{"key":"R235-20230908","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1016\/j.vaccine.2017.10.100","article-title":"Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B\/Victoria-Lineage in patients 60 years old or older during the 2015\/2016 influenza season.","volume":"35","author":"Puig-Barber\u00e0","year":"2017","journal-title":"Vaccine"},{"key":"R236-20230908","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/irv.12520","article-title":"2015\/16 I-MOVE\/I-MOVE+ multicentre case-control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.","volume":"12","author":"Kissling","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"R237-20230908","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1017\/S0950268817002709","article-title":"Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012-2016.","volume":"146","author":"M\u00f6hl","year":"2018","journal-title":"Epidemiol Infect"},{"key":"R238-20230908","doi-asserted-by":"crossref","first-page":"pii=1700318","DOI":"10.2807\/1560-7917.ES.2018.23.8.17-00318","article-title":"Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016\/17.","volume":"23","author":"Mira-Iglesias","year":"2018","journal-title":"Euro Surveill"},{"key":"R239-20230908","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.vaccine.2018.02.093","article-title":"Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011\/12 through 2013\/14 influenza seasons: a pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).","volume":"36","author":"Nichols","year":"2018","journal-title":"Vaccine"},{"key":"R240-20230908","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/cid\/ciy202","article-title":"Dose-dependent negative effects of prior multiple vaccinations against influenza A and influenza B among school children: a Study of Kamigoto Island in Japan during the 2011\/12, 2012\/13 and 2013\/14 Influenza Seasons.","volume":"67","author":"Saito","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R241-20230908","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/cid\/cix1013","article-title":"Seasonal influenza vaccine effectiveness in preventing laboratory-confirmed influenza in primary care in Israel, 2016-2017 Season: insights into novel age-specific analysis.","volume":"66","author":"Stein","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R242-20230908","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.vaccine.2018.01.024","article-title":"Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016.","volume":"36","author":"Sugaya","year":"2018","journal-title":"Vaccine"},{"key":"R243-20230908","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.vaccine.2018.04.037","article-title":"Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged \u226565 years in Japan.","volume":"36","author":"Suzuki","year":"2018","journal-title":"Vaccine"},{"key":"R244-20230908","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/irv.12562","article-title":"Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: results of the European I-MOVE multicentre test-negative case\u2013control study, 2011\/2012-2016\/2017.","volume":"12","author":"Valenciano","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"R245-20230908","doi-asserted-by":"crossref","first-page":"pii=1700026","DOI":"10.2807\/1560-7917.ES.2018.23.7.17-00026","article-title":"Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014\/15 and 2015\/16.","volume":"23","author":"Yaron-Yakoby","year":"2018","journal-title":"Euro Surveill"},{"key":"R246-20230908","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.vaccine.2018.04.081","article-title":"Influenza vaccine effectiveness in hospitalised Hong Kong children: feasibility of estimates from routine surveillance data.","volume":"36","author":"Yeung","year":"2018","journal-title":"Vaccine"},{"key":"R247-20230908","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1080\/21645515.2018.1441655","article-title":"Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China.","volume":"14","author":"Zhang","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"R248-20230908","doi-asserted-by":"crossref","first-page":"pii=1800057","DOI":"10.2807\/1560-7917.ES.2018.23.7.18-00057","article-title":"Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017\/18.","volume":"23","author":"Castilla","year":"2018","journal-title":"Euro Surveill"},{"key":"R249-20230908","doi-asserted-by":"crossref","first-page":"pii=1800062","DOI":"10.2807\/1560-7917.ES.2018.23.8.18-00062","article-title":"Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017\/18.","volume":"23","author":"Chiu","year":"2018","journal-title":"Euro Surveill"},{"key":"R250-20230908","doi-asserted-by":"crossref","first-page":"pii=1800086","DOI":"10.2807\/1560-7917.ES.2018.23.9.18-00086","article-title":"Interim 2017\/18 influenza seasonal vaccine effectiveness: combined results from five European studies.","volume":"23","author":"Rondy","year":"2018","journal-title":"Euro Surveill"},{"key":"R251-20230908","doi-asserted-by":"crossref","first-page":"pii=1800035","DOI":"10.2807\/1560-7917.ES.2018.23.5.18-00035","article-title":"Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017\/18 vaccine effectiveness, Canada, January 2018.","volume":"23","author":"Skowronski","year":"2018","journal-title":"Euro Surveill"},{"key":"R252-20230908","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/infdis\/jiv177","article-title":"Integrated sentinel surveillance linking genetic, antigenic, and epidemiologic monitoring of influenza vaccine-virus relatedness and effectiveness during the 2013-2014 influenza season.","volume":"212","author":"Skowronski","year":"2015","journal-title":"J Infect Dis"},{"key":"R253-20230908","first-page":"127","article-title":"Influenza vaccine effectiveness to prevent medically attended laboratory confirmed influenza during season 2010-2011 in Romania: a case control study.","volume":"20","author":"Pitigoi","year":"2012","journal-title":"Rev Romana Med Lab"},{"key":"R254-20230908","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/cid\/ciu680","article-title":"Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons.","volume":"59","author":"McLean","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R255-20230908","article-title":"Assessment of seasonal influenza vaccine effectiveness in patients from a central Italy reference hospital: pitfalls and intricacies from a pilot case\u2013control study.","volume":"11","author":"Simona","year":"2014","journal-title":"Epidemiol Biostat Public Health"},{"key":"R256-20230908","first-page":"9","article-title":"Circulating influenza viruses and the effectiveness of seasonal influenza vaccine in Romania, season 2012-2013.","volume":"23","author":"Pitigoi","year":"2015","journal-title":"Rev Romana Med Lab"},{"key":"R257-20230908","doi-asserted-by":"crossref","first-page":"e20153279","DOI":"10.1542\/peds.2015-3279","article-title":"Seasonal effectiveness of live attenuated and inactivated influenza vaccine.","volume":"137","author":"Chung","year":"2016","journal-title":"Pediatrics"},{"key":"R258-20230908","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.vaccine.2015.11.016","article-title":"Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.","volume":"34","author":"Cowling","year":"2016","journal-title":"Vaccine"},{"key":"R259-20230908","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1017\/S0950268816000819","article-title":"Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.","volume":"144","author":"Sullivan","year":"2016","journal-title":"Epidemiol Infect"},{"key":"R260-20230908","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1016\/j.vaccine.2013.06.103","article-title":"Variable definitions of the influenza season and their impact on vaccine effectiveness estimates.","volume":"31","author":"Sullivan","year":"2013","journal-title":"Vaccine"},{"key":"R261-20230908","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1016\/j.vaccine.2016.05.034","article-title":"Influenza vaccine effectiveness: maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.","volume":"34","author":"Radin","year":"2016","journal-title":"Vaccine"},{"key":"R262-20230908","doi-asserted-by":"crossref","first-page":"pii=1700645","DOI":"10.2807\/1560-7917.ES.2017.22.41.17-00645","article-title":"Low 2016\/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017\/18 season.","volume":"22","author":"Rondy","year":"2017","journal-title":"Euro Surveill"},{"key":"R263-20230908","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jiac.2018.05.012","article-title":"Effectiveness of quadrivalent influenza vaccine based on the test-negative control study in children during the 2016-2017 season.","volume":"24","author":"Ando","year":"2018","journal-title":"J Infect Chemother"},{"key":"R264-20230908","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/cid\/ciy597","article-title":"Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel australian hospitals in 2017: results from the PAEDS-FluCAN collaboration.","volume":"68","author":"Blyth","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R265-20230908","doi-asserted-by":"crossref","first-page":"e181514","DOI":"10.1001\/jamapediatrics.2018.1514","article-title":"Effectiveness of live attenuated vs inactivated influenza vaccines in children during the 2012-2013 through 2015-2016 influenza seasons in Alberta, Canada: a Canadian Immunization Research Network (CIRN) Study.","volume":"172","author":"Buchan","year":"2018","journal-title":"JAMA Pediatr"},{"key":"R266-20230908","doi-asserted-by":"crossref","first-page":"e0201497","DOI":"10.1371\/journal.pone.0201497","article-title":"Severe Acute Respiratory Infection (SARI) sentinel surveillance in the country of Georgia, 2015-2017.","volume":"13","author":"Chakhunashvili","year":"2018","journal-title":"PLoS One"},{"key":"R267-20230908","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/21645515.2018.1514222","article-title":"Seasonal influenza vaccine effectiveness at primary care level, Hong Kong SAR, 2017\/2018 winter.","volume":"15","author":"Chan","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"R268-20230908","doi-asserted-by":"crossref","first-page":"167","DOI":"10.15585\/mmwr.mm6606a3","article-title":"Interim estimates of 2016-17 seasonal influenza vaccine effectiveness - United States, February 2017.","volume":"66","author":"Flannery","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R269-20230908","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00431-018-3145-7","article-title":"Effectiveness of inactivated quadrivalent influenza vaccine in the 2015\/2016 season as assessed in both a test-negative case\u2013control study design and a traditional case\u2013control study design.","volume":"177","author":"Kimiya","year":"2018","journal-title":"Eur J Pediatr"},{"key":"R270-20230908","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pulmoe.2018.05.004","article-title":"Moderate influenza vaccine effectiveness in a B mismatch season: preliminary results from the 2017\/2018 season in Portugal.","volume":"24","author":"Machado","year":"2018","journal-title":"Pulmonology"},{"key":"R271-20230908","doi-asserted-by":"crossref","first-page":"pii=1800092","DOI":"10.2807\/1560-7917.ES.2018.23.39.1800092","article-title":"Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010\/11 to 2016\/17.","volume":"23","author":"Pebody","year":"2018","journal-title":"Euro Surveill"},{"key":"R272-20230908","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jiac.2018.07.013","article-title":"Influenza vaccine showed a good preventive effect against influenza-associated hospitalization among elderly patients, during the 2016\/17 season in Japan.","volume":"24","author":"Seki","year":"2018","journal-title":"J Infect Chemother"},{"key":"R273-20230908","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1016\/j.vaccine.2018.07.065","article-title":"Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016\/17 season.","volume":"36","author":"Shinjoh","year":"2018","journal-title":"Vaccine"},{"key":"R274-20230908","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1016\/j.vaccine.2018.08.075","article-title":"The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.","volume":"36","author":"Tam","year":"2018","journal-title":"Vaccine"},{"key":"R275-20230908","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/cid\/ciy737","article-title":"Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010-2016.","volume":"68","author":"Thompson","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R276-20230908","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1016\/j.vaccine.2018.07.028","article-title":"Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.","volume":"36","author":"Thompson","year":"2018","journal-title":"Vaccine"},{"key":"R277-20230908","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1016\/j.vaccine.2018.07.077","article-title":"Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: a test-negative case-control study in Beijing, China, 2016\/17 season.","volume":"36","author":"Wu","year":"2018","journal-title":"Vaccine"},{"key":"R278-20230908","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1016\/j.vaccine.2018.07.017","article-title":"The 2015-2016 influenza epidemic in Beijing, China: unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"key":"R279-20230908","first-page":"183","article-title":"Monovalent rotavirus vaccine effectiveness and impact on rotavirus hospitalizations in Zanzibar, Tanzania: data from the first 3 years after introduction.","volume":"215","author":"Abeid","year":"2017","journal-title":"J Infect Dis"},{"issue":"suppl 2","key":"R280-20230908","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/ciw014","article-title":"Impact and effectiveness of monovalent rotavirus vaccine against severe rotavirus Diarrhea in Ghana.","volume":"62","author":"Armah","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"R281-20230908","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/cid\/civ1183","article-title":"Population impact and effectiveness of monovalent rotavirus vaccination in Urban Malawian children 3 years after vaccine introduction: ecological and case-control analyses.","volume":"62","author":"Bar-Zeev","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R282-20230908","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.1016\/j.vaccine.2012.10.049","article-title":"Rotavirus vaccination effectiveness: a case-case study in the EDICS project, Castell\u00f3n (Spain).","volume":"30","author":"Bellido-Blasco","year":"2012","journal-title":"Vaccine"},{"issue":"suppl 2","key":"R283-20230908","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/cid\/civ1206","article-title":"A preliminary assessment of rotavirus vaccine effectiveness in Zambia.","volume":"62","author":"Beres","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R284-20230908","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.vaccine.2011.11.071","article-title":"Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain.","volume":"30","author":"Castilla","year":"2012","journal-title":"Vaccine"},{"key":"R285-20230908","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/INF.0000000000000105","article-title":"Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.","volume":"33","author":"Chang","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R286-20230908","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/649843","article-title":"Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.","volume":"201","author":"Correia","year":"2010","journal-title":"J Infect Dis"},{"key":"R287-20230908","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1542\/peds.2012-3804","article-title":"Effectiveness of monovalent and pentavalent rotavirus vaccine.","volume":"132","author":"Cortese","year":"2013","journal-title":"Pediatrics"},{"key":"R288-20230908","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1542\/peds.2011-1006","article-title":"Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine.","volume":"128","author":"Cortese","year":"2011","journal-title":"Pediatrics"},{"key":"R289-20230908","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.vaccine.2014.03.064","article-title":"Effectiveness of the monovalent rotavirus vaccine in Colombia: a case-control study.","volume":"32","author":"Cotes-Cantillo","year":"2014","journal-title":"Vaccine"},{"key":"R290-20230908","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2015.10.118","article-title":"Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.","volume":"33","author":"Doll","year":"2015","journal-title":"Vaccine"},{"key":"R291-20230908","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.vaccine.2013.03.072","article-title":"Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs.","volume":"31","author":"Donauer","year":"2013","journal-title":"Vaccine"},{"key":"R292-20230908","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12887-017-0916-7","article-title":"Effectiveness of rotavirus vaccines against hospitalisations in Japan.","volume":"17","author":"Fujii","year":"2017","journal-title":"BMC Pediatr"},{"issue":"suppl 2","key":"R293-20230908","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/civ1208","article-title":"Effectiveness of monovalent and pentavalent rotavirus vaccines in Guatemala.","volume":"62","author":"Gasta\u00f1aduy","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"R294-20230908","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/cid\/civ1207","article-title":"Effectiveness of monovalent rotavirus vaccine after programmatic implementation in Botswana: a multisite prospective Case-Control Study.","volume":"62","author":"Gasta\u00f1aduy","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"R295-20230908","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1093\/cid\/civ1209","article-title":"Impact of rotavirus vaccine introduction and vaccine effectiveness in the Republic of Moldova.","volume":"62","author":"Gheorghita","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R296-20230908","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1473-3099(14)70940-5","article-title":"Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study.","volume":"14","author":"Groome","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R297-20230908","first-page":"317","article-title":"Sustained high effectiveness of RotaTeq on hospitalizations attributable to rotavirus-associated gastroenteritis during 4 years in Finland.","volume":"6","author":"Hemming-Harlo","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R298-20230908","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2016.01.042","article-title":"Sustained effectiveness of monovalent and pentavalent rotavirus vaccines in children.","volume":"172","author":"Immergluck","year":"2016","journal-title":"J Pediatr"},{"key":"R299-20230908","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/INF.0000000000000647","article-title":"Case control study of rotavirus vaccine effectiveness in Portugal during 6 years of private market use.","volume":"34","author":"Marlow","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R300-20230908","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1097\/INF.0b013e31822a8527","article-title":"Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.","volume":"30","author":"Mast","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R301-20230908","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/j.vaccine.2015.08.027","article-title":"Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis.","volume":"33","author":"Mohammed","year":"2015","journal-title":"Vaccine"},{"key":"R302-20230908","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cmi.2017.04.018","article-title":"Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.","volume":"24","author":"Muhsen","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"R303-20230908","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4161\/hv.6.6.11759","article-title":"Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study.","volume":"6","author":"Muhsen","year":"2010","journal-title":"Hum Vaccin"},{"issue":"suppl 2","key":"R304-20230908","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1093\/cid\/civ1017","article-title":"Effectiveness of pentavalent rotavirus vaccine against a diverse range of circulating strains in Nicaragua.","volume":"62","author":"Patel","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R305-20230908","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1542\/peds.2011-3478","article-title":"Duration of protection of pentavalent rotavirus vaccination in Nicaragua.","volume":"130","author":"Patel","year":"2012","journal-title":"Pediatrics"},{"key":"R306-20230908","doi-asserted-by":"crossref","first-page":"f3726","DOI":"10.1136\/bmj.f3726","article-title":"Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study.","volume":"346","author":"Patel","year":"2013","journal-title":"BMJ"},{"key":"R307-20230908","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/cix494","article-title":"Impact of rotavirus vaccine introduction and postintroduction etiology of diarrhea requiring hospital admission in Haydom, Tanzania, a Rural African Setting.","volume":"65","author":"Platts-Mills","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"R308-20230908","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1093\/cid\/civ1026","article-title":"Sustained effectiveness of rotavirus vaccine against very severe rotavirus disease through the second year of life, Bolivia 2013-2014.","volume":"62","author":"Pringle","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"R309-20230908","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1093\/cid\/ciw045","article-title":"Impact and effectiveness of monovalent rotavirus vaccine in Armenian Children.","volume":"62","author":"Sahakyan","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R310-20230908","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1016\/j.vaccine.2010.06.109","article-title":"Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children.","volume":"28","author":"Sahni","year":"2010","journal-title":"Vaccine"},{"key":"R311-20230908","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/cid\/ciq101","article-title":"Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia.","volume":"52","author":"Snelling","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R312-20230908","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1542\/peds.2010-3722","article-title":"Effectiveness of pentavalent rotavirus vaccine against severe disease.","volume":"128","author":"Staat","year":"2011","journal-title":"Pediatrics"},{"key":"R313-20230908","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3201\/eid1908.130461","article-title":"Comparison of 2 assays for diagnosing rotavirus and evaluating vaccine effectiveness in children with gastroenteritis.","volume":"19","author":"Tate","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"suppl 2","key":"R314-20230908","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1093\/cid\/civ1016","article-title":"Effectiveness of pentavalent rotavirus vaccine under conditions of routine use in Rwanda.","volume":"62","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R315-20230908","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1016\/j.vaccine.2016.08.047","article-title":"Rotavirus vaccine effectiveness in Hong Kong children.","volume":"34","author":"Yeung","year":"2016","journal-title":"Vaccine"},{"key":"R316-20230908","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/INF.0b013e3181ed18ab","article-title":"Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital.","volume":"29","author":"Boom","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl 2","key":"R317-20230908","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1093\/cid\/civ1012","article-title":"Real-world effectiveness of pentavalent rotavirus vaccine among Bedouin and Jewish Children in Southern Israel.","volume":"62","author":"Leshem","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R318-20230908","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4161\/hv.7.7.15576","article-title":"Effectiveness of rotavirus vaccination in Spain.","volume":"7","author":"Martin\u00f3n-Torres","year":"2011","journal-title":"Hum Vaccin"},{"key":"R319-20230908","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/cid\/cit164","article-title":"Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.","volume":"57","author":"Payne","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R320-20230908","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/cid\/civ872","article-title":"Long-term consistency in rotavirus vaccine protection: RV5 and RV1 vaccine effectiveness in US Children, 2012-2013.","volume":"61","author":"Payne","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R321-20230908","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/INF.0000000000000086","article-title":"Impact and effectiveness of RotaTeq\u00ae vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.","volume":"32","author":"Vesikari","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R322-20230908","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1016\/j.vaccine.2018.01.071","article-title":"Detection of rotavirus before and after monovalent rotavirus vaccine introduction and vaccine effectiveness among children in mainland Tanzania.","volume":"36","author":"Jani","year":"2018","journal-title":"Vaccine"},{"key":"R323-20230908","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/INF.0000000000001828","article-title":"Evaluation of the influence of gastrointestinal coinfections on rotavirus vaccine effectiveness in Botswana.","volume":"37","author":"Mokomane","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R324-20230908","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2188\/jea.JE20180054","article-title":"Case-Control Study of rotavirus vaccine effectiveness compared to test-negative controls or hospital controls.","volume":"29","author":"Araki","year":"2019","journal-title":"J Epidemiol"},{"key":"R325-20230908","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/j.vaccine.2018.07.007","article-title":"Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.","volume":"36","author":"Araki","year":"2018","journal-title":"Vaccine"},{"key":"R326-20230908","doi-asserted-by":"crossref","first-page":"14291","DOI":"10.1038\/s41598-018-32595-9","article-title":"Effectiveness of monovalent rotavirus vaccine in the Philippines.","volume":"8","author":"Lopez","year":"2018","journal-title":"Sci Rep"},{"key":"R327-20230908","doi-asserted-by":"crossref","first-page":"e28435","DOI":"10.1371\/journal.pone.0028435","article-title":"Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales.","volume":"6","author":"Andrews","year":"2011","journal-title":"PLoS One"},{"key":"R328-20230908","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R329-20230908","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"R330-20230908","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.vaccine.2004.06.016","article-title":"Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia.","volume":"23","author":"Andrews","year":"2004","journal-title":"Vaccine"},{"key":"R331-20230908","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1086\/375782","article-title":"Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults.","volume":"188","author":"Benin","year":"2003","journal-title":"J Infect Dis"},{"key":"R332-20230908","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.1993.03510150060030","article-title":"Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"key":"R333-20230908","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1016\/j.vaccine.2012.04.017","article-title":"Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period.","volume":"30","author":"De Serres","year":"2012","journal-title":"Vaccine"},{"key":"R334-20230908","doi-asserted-by":"crossref","first-page":"20922","DOI":"10.2807\/1560-7917.ES2014.19.40.20922","article-title":"Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the region of Madrid, Spain, 2008-2011.","volume":"19","author":"Gutierrez Rodriguez","year":"2014","journal-title":"Euro Surveill"},{"key":"R335-20230908","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1016\/j.vaccine.2017.07.089","article-title":"Effectiveness of different vaccine schedules for heptavalent and 13-valent conjugate vaccines against pneumococcal disease in the community of Madrid.","volume":"35","author":"Latasa","year":"2017","journal-title":"Vaccine"},{"key":"R336-20230908","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.vaccine.2009.12.066","article-title":"Failure to vaccinate or failure of vaccine? Effectiveness of the 23-valent pneumococcal polysaccharide vaccine program in Indigenous adults in the Northern Territory of Australia.","volume":"28","author":"Moberley","year":"2010","journal-title":"Vaccine"},{"key":"R337-20230908","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2334-8-53","article-title":"The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003\/2004.","volume":"8","author":"Mooney","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R338-20230908","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.ijporl.2015.09.022","article-title":"Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine\u2019s effectiveness.","volume":"79","author":"Ochoa-Gondar","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R339-20230908","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12630","article-title":"Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.","volume":"19","author":"Olarte","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"R340-20230908","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1016\/j.vaccine.2010.05.021","article-title":"Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: an analysis using the indirect cohort method.","volume":"28","author":"R\u00fcckinger","year":"2010","journal-title":"Vaccine"},{"key":"R341-20230908","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"R342-20230908","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.vaccine.2006.11.065","article-title":"Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults.","volume":"25","author":"Singleton","year":"2007","journal-title":"Vaccine"},{"key":"R343-20230908","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","article-title":"Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study.","volume":"17","author":"Suzuki","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R344-20230908","doi-asserted-by":"crossref","first-page":"e0161257","DOI":"10.1371\/journal.pone.0161257","article-title":"Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany.","volume":"11","author":"van der Linden","year":"2016","journal-title":"PLoS One"},{"key":"R345-20230908","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1016\/j.vaccine.2015.10.007","article-title":"Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease.","volume":"33","author":"Verani","year":"2015","journal-title":"Vaccine"},{"key":"R346-20230908","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.vaccine.2014.02.048","article-title":"The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study.","volume":"32","author":"Wiemken","year":"2014","journal-title":"Vaccine"},{"key":"R347-20230908","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/ciy129","article-title":"Effectiveness of 7- and 13-Valent Pneumococcal conjugate vaccines in a schedule without a booster dose: a 10-year Observational Study.","volume":"67","author":"Jayasinghe","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R348-20230908","doi-asserted-by":"crossref","first-page":"e019034","DOI":"10.1136\/bmjopen-2017-019034","article-title":"Effectiveness of the 13-valent pneumococcal conjugate vaccine against adult pneumonia in Italy: a case-control study in a 2-year prospective cohort.","volume":"8","author":"Prato","year":"2018","journal-title":"BMJ Open"},{"key":"R349-20230908","first-page":"1498","article-title":"Effectiveness of 13-Valent Pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older US adults: a test-negative design.","volume":"67","author":"McLaughlin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R350-20230908","doi-asserted-by":"crossref","first-page":"f4249","DOI":"10.1136\/bmj.f4249","article-title":"Effectiveness of pertussis vaccines for adolescents and adults: case-control study.","volume":"347","author":"Baxter","year":"2013","journal-title":"BMJ"},{"key":"R351-20230908","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.vaccine.2017.05.008","article-title":"Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine.","volume":"35","author":"Klein","year":"2017","journal-title":"Vaccine"},{"key":"R352-20230908","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1542\/peds.2012-3836","article-title":"Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers.","volume":"131","author":"Klein","year":"2013","journal-title":"Pediatrics"},{"key":"R353-20230908","doi-asserted-by":"crossref","first-page":"E399","DOI":"10.1503\/cmaj.160193","article-title":"Effectiveness of pertussis vaccination and duration of immunity.","volume":"188","author":"Schwartz","year":"2016","journal-title":"CMAJ"},{"key":"R354-20230908","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/j.vaccine.2015.04.084","article-title":"Estimates of pertussis vaccine effectiveness in United States air force pediatric dependents.","volume":"33","author":"Wolff","year":"2015","journal-title":"Vaccine"},{"key":"R355-20230908","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children.","volume":"367","author":"Klein","year":"2012","journal-title":"N Engl J Med"},{"key":"R356-20230908","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.vaccine.2015.12.004","article-title":"Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design.","volume":"34","author":"Ali","year":"2016","journal-title":"Vaccine"},{"key":"R357-20230908","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1016\/j.vaccine.2017.09.025","article-title":"Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.","volume":"35","author":"Franke","year":"2017","journal-title":"Vaccine"},{"key":"R358-20230908","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/S2214-109X(16)30211-X","article-title":"Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.","volume":"4","author":"Azman","year":"2016","journal-title":"Lancet Glob Health"},{"key":"R359-20230908","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.vaccine.2015.03.073","article-title":"Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.","volume":"33","author":"Wierzba","year":"2015","journal-title":"Vaccine"},{"key":"R360-20230908","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(07)60531-5","article-title":"Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.","volume":"369","author":"Grassly","year":"2007","journal-title":"Lancet"},{"key":"R361-20230908","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJMoa0803259","article-title":"Effectiveness of immunization against paralytic poliomyelitis in Nigeria.","volume":"359","author":"Jenkins","year":"2008","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"R362-20230908","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1093\/infdis\/jiu261","article-title":"Effectiveness of oral polio vaccination against paralytic poliomyelitis: a matched case-control study in Somalia.","volume":"210","author":"Mahamud","year":"2014","journal-title":"J Infect Dis"},{"key":"R363-20230908","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(12)60648-5","article-title":"The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis.","volume":"380","author":"O\u2019Reilly","year":"2012","journal-title":"Lancet"},{"key":"R364-20230908","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eimc.2015.11.020","article-title":"Meningococcal C conjugate vaccine: impact of a vaccination program and long-term effectiveness in Navarra, Spain, 2000-2014.","volume":"34","author":"Morales","year":"2016","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R365-20230908","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ije\/24.5.1050","article-title":"Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.","volume":"24","author":"Noronha","year":"1995","journal-title":"Int J Epidemiol"},{"key":"R366-20230908","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/S0264-410X(02)00162-7","article-title":"The effectiveness of serogroup C meningococcal vaccine estimated from routine surveillance data.","volume":"20","author":"Rivest","year":"2002","journal-title":"Vaccine"},{"key":"R367-20230908","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.vaccine.2015.04.067","article-title":"Field evaluation of measles vaccine effectiveness among children in the Democratic Republic of Congo.","volume":"33","author":"Doshi","year":"2015","journal-title":"Vaccine"},{"key":"R368-20230908","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4161\/hv.27895","article-title":"Measles epidemic from 1951 to 2012 and vaccine effectiveness in Guangzhou, southern China.","volume":"10","author":"Yang","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R369-20230908","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/jtm.12178","article-title":"Effectiveness of the typhoid Vi vaccine in overseas travelers from England.","volume":"22","author":"Wagner","year":"2015","journal-title":"J Travel Med"},{"key":"R370-20230908","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"key":"R371-20230908","first-page":"757","article-title":"Effectiveness of human papillomavirus vaccination on prevalence of vaccine genotypes in young sexually active women in France.","volume":"215","author":"Heard","year":"2017","journal-title":"J Infect Dis"},{"key":"R372-20230908","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2471\/BLT.07.045336","article-title":"Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda.","volume":"86","author":"Lewis","year":"2008","journal-title":"Bull World Health Organ"},{"key":"R373-20230908","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.vaccine.2013.02.053","article-title":"The test-negative design for estimating influenza vaccine effectiveness.","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"R374-20230908","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s12879-017-2838-2","article-title":"A comparison of the test-negative and the traditional case\u2013control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.","volume":"17","author":"Shi","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R375-20230908","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1016\/j.vaccine.2017.10.107","article-title":"On the bias of estimates of influenza vaccine effectiveness from test-negative studies.","volume":"35","author":"Ainslie","year":"2017","journal-title":"Vaccine"},{"key":"R376-20230908","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.vaccine.2013.04.026","article-title":"The case test-negative design for studies of the effectiveness of influenza vaccine.","volume":"31","author":"Foppa","year":"2013","journal-title":"Vaccine"},{"key":"R377-20230908","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.vaccine.2017.12.022","article-title":"The impact of selection bias on vaccine effectiveness estimates from test-negative studies.","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"key":"R378-20230908","article-title":"Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies.","author":"Jackson","year":"2019","journal-title":"Vaccine"},{"key":"R379-20230908","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/aje\/kwy163","article-title":"Measurement of vaccine direct effects under the test-negative design.","volume":"187","author":"Lewnard","year":"2018","journal-title":"Am J Epidemiol"},{"key":"R380-20230908","first-page":"129","article-title":"Pneumococcal vaccines: WHO position paper, 2012.","volume":"14","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"R382-20230908","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/1471-2334-10-320","article-title":"Evaluation of an influenza-like illness case definition in the diagnosis of influenza among patients with acute febrile illness in Cambodia.","volume":"10","author":"Kasper","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R383-20230908","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R384-20230908","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14760584.2017.1362339","article-title":"Streptococcus pneumoniae serotype 19A: worldwide epidemiology.","volume":"16","author":"Isturiz","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"R385-20230908","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2431-10-4","article-title":"Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?","volume":"10","author":"Hausdorff","year":"2010","journal-title":"BMC Pediatr"},{"key":"R386-20230908","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/cid\/cix673","article-title":"Pan-serotype reduction in progression of streptococcus pneumoniae to otitis media after rollout of pneumococcal conjugate vaccines.","volume":"65","author":"Lewnard","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R387-20230908","doi-asserted-by":"crossref","first-page":"e1001107","DOI":"10.1371\/journal.pmed.1001107","article-title":"Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.","volume":"8","author":"Roca","year":"2011","journal-title":"PLoS Med"},{"key":"R388-20230908","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/01.inf.0000435805.25366.64","article-title":"Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization.","volume":"32","author":"Nzenze","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R389-20230908","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination.","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"R390-20230908","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"key":"R391-20230908","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors.","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"key":"R392-20230908","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ije\/21.5.1014","article-title":"The measurement and interpretation of age-specific vaccine efficacy.","volume":"21","author":"Farrington","year":"1992","journal-title":"Int J Epidemiol"},{"key":"R393-20230908","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/cid\/ciy773","article-title":"Challenges of vaccine effectiveness and waning studies.","volume":"68","author":"Lipsitch","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R394-20230908","doi-asserted-by":"crossref","first-page":"g1458","DOI":"10.1136\/bmj.g1458","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia.","volume":"348","author":"Crowe","year":"2014","journal-title":"BMJ"},{"key":"R395-20230908","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1016\/j.vaccine.2007.06.032","article-title":"Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda.","volume":"25","author":"Muganga","year":"2007","journal-title":"Vaccine"},{"key":"R396-20230908","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2334-14-77","article-title":"A sham case-control study of effectiveness of DTP-Hib-hepatitis B vaccine against rotavirus acute gastroenteritis in Kenya.","volume":"14","author":"Khagayi","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R397-20230908","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/infdis\/124.2.155","article-title":"Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.","volume":"124","author":"Top","year":"1971","journal-title":"J Infect Dis"},{"key":"R398-20230908","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.1966.03100060093026","article-title":"Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease.","volume":"195","author":"Edmondson","year":"1966","journal-title":"JAMA"},{"key":"R399-20230908","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/oxfordjournals.aje.a121306","article-title":"Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.","volume":"94","author":"Top","year":"1971","journal-title":"Am J Epidemiol"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T22:40:01Z","timestamp":1721860801000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001116"}},"subtitle":["A Systematic Review of Methodology"],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":397,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001116","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}